Top Managed Healthcare Companies To Invest In Right Now

Demand for products and services in the agriculture, government and industrial sectors has helped Alamo Group Inc. (ALG) jump since closing at the end of 2012 at $32.64. Since then the company has surged to a 52-week high of $44.13, although it has dropped back to move in a range of about $40.00 to $41.00 per share over the last month.

The fundamentals remain in place for the equipment manufacturer and distributor to continue to grow for the rest of 2013, and 2014 looks pretty good as well, although not as convincing as the rest of this year.

One of the major challenges Alamo Group faces is it sells mostly to mature markets, with North America, England, France, and Australia being the primary regions it serves. In varying degrees those areas continue to struggle economically, making the long-term outlook for Alamo not as compelling as the short-term outlook.

Top Managed Healthcare Companies To Invest In Right Now: Xerium Technologies Inc.(XRM)

Xerium Technologies, Inc. manufactures and supplies consumable products used in the production of paper clothing and roll covers primarily in North America, Europe, South America, and the Asia-Pacific. It operates in two segments, Clothing and Roll Covers. The Clothing segment provides various types of industrial textiles used on paper-making machines and other industrial applications. This segment offers forming fabrics, press felts, and dryer fabrics; and fabrics used in other industrial applications, such as pulp, steel, plastics, leather, and textiles manufacturing. The Roll Covers segment manufactures, refurbishes, and replaces roll covers for working rolls, including vacuum rolls and press rolls; calendar rolls; and coater rolls that are used on paper-making machines. This segment also refurbishes previously installed roll covers; provides mechanical maintenance and repair services for the internal mechanisms of rolls used on paper-making machines; and manufactures a nd repairs spreader rolls. The company markets its products through its direct sales force under Huyck Wangner, Weavexx, Stowe Woodward, Mount Hope, Robec, and Xibe brand names. Xerium Technologies, Inc. was founded in 1999 and is headquartered in Raleigh, North Carolina.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One cyclical consumer goods player that’s starting to trend within range of triggering a near-term breakout trade is Xerium Technologies (XRM), a manufacturer and supplier of two types of consumable products, clothing and roll covers, used mainly in the production of paper. This stock has been on fire so far in 2013, with shares up sharply by 313%.

    If you take a look at the chart for Xerium Technologies, you’ll notice that this stock has been uptrending strong for the last two months and change, with shares moving higher from its low of $9.94 to its recent high of $12.97 a share. During that uptrend, shares of XRM have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of XRM within range of triggering a near-term breakout trade.

    Traders should now look for long-biased trades in XRM if it manages to break out above some near-term overhead resistance at $12.97 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 100,685 shares. If that breakout triggers soon, then XRM will set up to re-test or possibly take out its 52-week high at $14.04 a share. Any high-volume move above that level will then give XRM a chance to tag its next major overhead resistance levels at $18 to $20 a share.

    Traders can look to buy XRM off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12.28, or near its 50-day at $11.35 a share. One can also buy XRM off strength once it takes out $12.97 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Xerium Technologies (NYSE: XRM  ) , whose recent revenue and earnings are plotted below.

Top Managed Healthcare Companies To Invest In Right Now: Bri-Chem Corp (BRY)

Bri-Chem Corp. is a North American distributor, blender, and manufacturer of drilling fluids and steel pipe for the oil and gas industry in North America. The Company operates in three segments: Fluids, Steel Distribution and Steel Manufacturing. Its Fluids segment includes the sale of fluids and chemical additives to the resource and industrial markets. The Steel Distribution segment includes the sale of tubular steel products to the resource, industrial and construction industries. The Steel Manufacturing segment produces seamless steel pipe through a thermal expansion process for sale to steel pipe distributors in North America. On May 31, 2011, it acquired all membership interest in Bri-Chem Supply Corp, LLC (BSU) and Stryker Transportation Ltd. (Stryker). In September 2013, Bri-Chem Corp acquired the cement blending business assets of Sun Coast Materials Co. and certain additional transportation assets from its affiliate Acme Trucking, Inc. Advisors’ Opinion:

  • [By Victor Selva]

    Competitors such as Sandridge Energy Inc. (SD), Penn Virginia Corp. (PVA), Newfield Exploration Co. (NFX) also have a negative ROE. An alternative could be Cabot Oil &Gas Corp. (COG), Range Resources Corp. (RRC), SM Energy Co. (SM), Pioneer Natural Resources Co. (PXD) or Whiting Petroleum Corp (WLL), Berry Petroleum Co. (BRY), but for investors searching for a higher ratio, Continental Resources Inc. (CLR) will be the best option.

  • [By Robert Rapier]

    We got numerous questions about Linn Energy (Nasdaq: LINE) in the chat. I commented on this in last week’s MLP Investing Insider, but it bears repeating here as there is obviously still a lot of interest. Igor’s answer to this question was “I expect the merger to close by year’s end, but I think Linn has some structural issues that go beyond [pending merger partner Berry Petroleum (NYSE: BRY)] with its debt load and past acquisition quality, so I’m steering clear. There are better upstream MLPs in our portfolios.”

  • [By Ben Levisohn]

    It’s the moment investors in Linn Energy (LINE) have been waiting for–the SEC’s decision to approve or block it merger with Berry Petroleum (BRY).

  • [By Ben Levisohn]

    So yes, the numbers were good enough to make Raymond James’ analyst Kevin Smith say that Linn “has finally turned the corner.” But even bullish analysts note that the numbers are kind of, well, beside the point until Linn’s merger with Berry Petroleum (BRY) is resolved. RBC Capital Markets analyst John Ragozzino and team explain:

Top Managed Healthcare Companies To Invest In Right Now: Zinco Do Brasil Inc (ZNBR)

Zinco do Brasil Inc., formerly TurkPower Corporation, incorporated on November 4, 2004, has been a Turkish-American consulting and service operations firm and junior mining company. TurkPower offered its domestic and international clients consulting services and plans to act as a full service operator for wind, hydro, solar, coal and geothermal energy parks in Turkey.

In November 2011, the Company ceased all operations in Turkey. During the fiscal year ended May 31, 2012 (fiscal 2012) the Company impaired its entire mining company investment.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap mining stocks Discovery Minerals Ltd (OTCMKTS: DSCR), Zinco Do Brasil Inc (OTCMKTS: ZNBR) and Amalgamated Gold and Silver Inc (OTCMKTS: BCHS) have been getting some extra attention lately as one stock surged last Friday while the other two are or have been in the past, the subject of paid promotions. It goes without saying though that small cap mining stocks tend to be riskier than your average stock. But do these three small cap mining stocks have what it takes to produce a mother lode for investors? Here is a deeper dig into all three:

Top Managed Healthcare Companies To Invest In Right Now: Align Technology Inc.(ALGN)

Align Technology, Inc., a medical device company, designs, manufactures, and markets clear aligner systems or Invisalign systems, intra-oral scanners, and computer-aided design (CAD) and computer-aided manufacturing (CAM) restorative models used in dentistry, orthodontics, and dental records storage in North America and Internationally. The company?s clear aligner products include Invisalign Full for the treatment of malocclusions; Invisalign Express and Invisalign Lite solutions for less complex orthodontic cases; Invisalign Teen, which is primarily marketed to orthodontists for treating malocclusion in teenage patients; Invisalign Assist for use in anterior alignment and aesthetically-oriented cases; and Vivera retainers for invisalign and non-invisalign patients. It also offers ancillary products comprising cleaning material and adjusting tools used by dental professionals during the course of treatment. In addition, the company provides iTero scanners; iOC scanners; a nd iTero dual scanner, which includes both the iTero restorative software and the iOC orthodontic software, as well as services comprising iTero restorative and OrthoCAD services. Further, it offers CAD/CAM services, such as iTero Models and Dies; OrthoCAD iCast and OrthoCAD iRecord that provides a digital alternative to traditional stone cast models, which allows for simplified storage and digital record retrieval; and OrthoCAD iQ, a computer-guided system for optimal placement of traditional brackets and customized indirect bonding tray system. The company distributes its products primarily directly to orthodontists and general practitioner dentists, as well as restorative dentists, including prosthodontists, periodontists, and oral surgeons. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.

Advisors’ Opinion:

  • [By Todd Campbell]

    If recent trends in employment and confidence continue, pent-up demand from consumers for dentistry could benefit a variety of other suppliers, too, including Align Technology  (NASDAQ: ALGN  ) , 3M (NYSE: MMM  ) , and Danaher (NYSE: DHR  ) .

  • [By John Udovich]

    Yesterday, small cap dental stock BIOLASE Inc (NASDAQ: BIOL) surged 17.69% after announcing it had received a license from the Health Canada-Medical Device Bureau to sell its EPIC dental soft-tissue diode laser systems throughout Canada, meaning its worth taking a closer look at the stock along with the performance of mid cap dental stocks like Sirona Dental Systems, Inc (NASDAQ: SIRO), DENTSPLY International Inc (NASDAQ: XRAY) and Align Technology, Inc (NASDAQ: ALGN).

  • [By Michael A. Robinson]

    The charting approach we use to find low-priced, fast-moving tech shares, my Real Demand Tracking System, is set up to find stocks like:

    Santarus Inc. (Nasdaq: SNTS): Shares of this small-cap biotech firm have gained 835% over the past five years. Cray Inc. (Nasdaq: CRAY): This small-cap leader in high-performance computing gave shareholders a five-year return of 855%. Align Technology Inc. (Nasdaq: ALGN): Over the past five years, share of this mid-cap medical device firm are up some 720%.

    As impressive as these gains are, the opportunity I’m closely watching today could be among the greatest we’ll see in our lifetimes.

  • [By Keith Speights]

    Bracing for success
    Preliminary third-quarter results sent shares of orthodontic medical device maker Align Technology (NASDAQ: ALGN  ) soaring by nearly 34% this week. Align blew past expectations on both the top and bottom lines.

Top Managed Healthcare Companies To Invest In Right Now: Ares Capital Corp (ARCC)

Ares Capital Corporation (Ares Capital), incorporated on April 16, 2004, is a specialty finance company, which is a closed-end, non-diversified management investment company. The Company’s wholly owned subsidiaries and vehicles managed or sub-managed by its wholly owned portfolio company, Ivy Hill Asset Management, L.P. (IHAM). It is externally managed by its investment adviser, Ares Capital Management LLC (Ares Capital Management or its investment adviser), a wholly owned subsidiary of Ares Management LLC (Ares Management), a global alternative asset manager. Ares Operations LLC (Ares Operations or administrator), its administrator, a wholly owned subsidiary of Ares Management, provides the administrative services. It invests in United States middle-market companies. It invests in first and second lien senior loans and mezzanine debt, which in some cases includes an equity component. It also makes preferred and/or common equity investments.

The Company’s portfolio company, IHAM, manages 10 unconsolidated credit vehicles and sub-manages or sub-advises four other unconsolidated credit vehicles (these vehicles managed or sub-managed/sub-advised by IHAM). It has also made direct investments in securities of certain of these vehicles. Ares Management’s (Ares) finance activities include the origination, acquisition and management of senior loans, bonds, mezzanine debt and special situation investments. Ares’ private equity activities focus on providing flexible, junior capital to middle-market companies.

The Company has an investment portfolio of first and second lien loans, mezzanine debt and equity investments in private middle-market companies. The Company and General Electric Capital Corporation and GE Global Sponsor Finance LLC (GE) co-invest through the Senior Secured Loan Fund LLC, which operates using the name Senior Secured Loan Program. As of December 31, 2011, the Senior Secured Loan Program (SSLP) consis ted of a portfolio of loans to 32 different borrowers and th! e portfolio companies in the SSLP are in industries similar to the companies in Ares Capital’s portfolio. It also makes preferred and/or common equity investments. It makes senior secured loans in the form of first and/or second lien loans. Its first and second lien loans have terms of three to 10 years. The list of the industries, in which it has invested include aerospace and defense, business services, consumer products, containers and packaging, education, energy, environmental services, financial services, food and beverage, healthcare services, investment funds and vehicles, manufacturing, restaurant and food services, retail, and telecommunications. It has made investments in its portfolio company, IHAM, which manages 10 unconsolidated credit vehicles: Ivy Hill Middle Market Credit Fund, Ltd. (Ivy Hill I), Ivy Hill Middle Market Credit Fund II, Ltd. (Ivy Hill II), Ivy Hill Middle Market Credit Fund III, Ltd. (Ivy Hill III), Ivy Hill Senior Debt Fund, L.P. and related vehicles (Ivy Hill SDF and, together with Ivy Hill I, Ivy Hill II and Ivy Hill III, the Ivy Hill Funds); Knightsbridge CLO 2007-1 Limited, Emporia Preferred Funding I, Ltd., Emporia Preferred Funding II, Ltd. and Emporia Preferred Funding III, Ltd. (collectively, the Emporia Funds), and Ares Private Debt Strategies Fund II, L.P. and Ares Private Debt Strategies Fund III, L.P. (collectively, the PDS Funds). In addition, IHAM serves as the sub-adviser/sub-manager for four others: CoLTS 2005-1 Ltd., CoLTS 2005-2 Ltd. and CoLTS 2007-1 Ltd. (collectively, the CoLTS Funds), and FirstLight Funding I, Ltd. (FirstLight).

Advisors’ Opinion:

  • [By Sally Jones]

    Highlight: Ares Capital Corporation (ARCC)

    The share price is currently around $17.57 or 5.9% off the 52-week high of $18.67. Its yield is 8.60%.

  • [By Dan Caplinger]

    Next Tuesday, Ares Capital (NASDAQ: ARCC  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed, knee-jerk reaction to news that turns out to be exactly the wrong move.

  • [By Eric Volkman]

    Ares Capital (NASDAQ: ARCC  ) now has a new man in the chief executive’s office. The business development company has tapped Michael Arougheti to be its CEO, in addition to a raft of other high-level appointments.

Top Managed Healthcare Companies To Invest In Right Now: Janus Capital Group Inc (SLS)

Janus Capital Group Inc., and its subsidiaries (JCG), incorporated on January 23, 1998, provide investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, other pooled investment vehicles, separate accounts and sub advised relationships (collectively referred to as investment products) in both domestic and international markets. JCG provides investment management competencies across a range of disciplines, including fundamental the United States and global equities (growth and value), mathematical equities, fixed income and alternatives through its subsidiaries, Janus Capital Management LLC (Janus), INTECH Investment Management LLC (INTECH) and Perkins Investment Management LLC (Perkins). JCG’s investment products are distributed through three primary channels: retail intermediary, institutional and international.

The institutional channel serves the United States corporations, endowments, foundations, Taft-Hartley funds and public fund clients and focuses on distribution direct to the plan sponsor and through consultants. As of December 31, 2012, assets in the institutional channel totaled 24% of total Company assets under management. The international channel primarily serves professional retail and institutional investors outside of the United States, including central and local government pension plans, corporate pension plans, multi-managers, insurance companies and private banks. International products are offered through separate accounts, sub advisory relationships and Janus Capital Funds Plc, a mutual fund trust. As of December 31, 2012, assets in the international channel totaled 11% of total Company assets under management. JCG operates international offices in London, Paris, Milan, Munich, Frankfurt, The Hague, Dubai, Zurich, Singapore, Hong Kong, Tokyo, Melbourne and Taipei. The retail intermediary channel serves financi al advisors, third-party intermediaries and retirement platf! orms in the United States. In addition, this channel serves existing individual investors who invest in JCG products through a mutual fund supermarket or directly with JCG. As of December 31, 2012, assets in the retail intermediary channel totaled 65% of total Company assets under management.

Janus

Janus manages primarily growth equity portfolios. As of December 31, 2012, Janus managed 63% of total Company assets under management. The Janus Overseas Fund is included in the assets managed by Janus and represented approximately 6% during the year ended December 31, 2012.

INTECH

INTECH has managed institutional portfolios. INTECH’s investment process is based on a mathematical theorem that seeks to add value for clients by capitalizing on the volatility in stock price movements. As of December 31, 2012, INTECH managed 26% of total Company assets under management.

Perkins

Perkins has managed value-dis ciplined investment products. With its fundamental research and careful consideration for downside risk, Perkins has established itself as a value manager. Perkins offers value equity investment products across a range of the United States asset classes and global equity. As of December 31, 2012, Perkins managed 11% of total Company assets under management.

Advisors’ Opinion:

  • [By Victor Selva]

    In addition, leading the solid rocket propellant market should ensure increased annual revenue. The new Space Launch System (SLS), for which ATK is working with the NASA, is expected be as successful as the Space Shuttle program years ago.

Top Managed Healthcare Companies To Invest In Right Now: Christopher & Banks Corporation (CBK)

Christopher & Banks Corporation, through its subsidiaries, operates retail stores that provide women’s apparel and accessories in the United States. The company designs, sources, and sells apparel catering to customers generally ranging in age from 45 to 60. Its stores offer knit tops, woven tops, jackets, sweaters, skirts, denim bottoms, bottoms made of other fabrications, and dresses in various sizes, as well as jewelry and accessories. As of March 13, 2013, the company operated 605 stores in 44 states, including 381 Christopher & Banks stores, 158 C.J. Banks stores, 41 dual stores, and 25 outlet stores. It also operates e-Commerce Web sites christopherandbanks.com and cjbanks.com. The company was formerly known as Braun’s Fashions Corporation and changed its name to Christopher & Banks Corporation in July 2000. Christopher & Banks Corporation was founded in 1956 and is headquartered in Plymouth, Minnesota.

Advisors’ Opinion:

  • [By Laura Brodbeck]

    Notable earnings releases expected on Thursday include:

    Dollar General Corporation (NYSE: DG) is expected to report fourth quarter EPS of $1.02 on revenue of $4.63 billion, compared to last year’s EPS of $0.97 on revenue of $4.21 billion. Kronos Worldwide Inc (NYSE: KRO) is expected to report fourth quarter EPS of $0.01 on revenue of $371.45 million, compared to last year’s loss of $0.12 per share on revenue of $396.80 million. Christopher & Banks Corporation (NYSE: CBK) is expected to report a fourth quarter loss of $0.03 on revenue of $106.64 million, compared to last year’s loss of $0.11 on revenue of $115.98 million.

    Economics

  • [By Laura Brodbeck]

    Wednesday

    Earnings Expected From: Christopher & Banks Corporation (NYSE: CBK), Brown Forman Corporation (NYSE: BFB), Express, Inc. (NYSE: EXPR), Avago Technologies (NASDAQ: AVGO) Economic Releases Expected: US nonfarm employment change, US trade balance, Canadian trade balance, US new home sales, US ISM non-manufacturing PMI

    Thursday

  • [By Sarah Jones]

    Commerzbank (CBK) added 2.6 percent to 11.09 euros. Germany’s second-largest lender reported a first-quarter loss of 94 million euros after booking costs associated with firing staff, compared with a profit of 355 million euros a year earlier. That still beat the average loss estimate of 153.7 million euros of seven analysts surveyed by Bloomberg.

Top Managed Healthcare Companies To Invest In Right Now: Teradyne Inc.(TER)

Teradyne, Inc., together with its subsidiaries, provides automatic test equipment products and services worldwide. The company operates in three segments: Semiconductor Test, Systems Test Group, and Wireless Test. The Semiconductor Test segment designs, manufactures, and sells semiconductor test products and services. Its test systems are used for wafer level and device package testing. These chips are used in automotive, communications, consumer, computer, and electronic game applications. This segment provides its products to integrated device manufacturers (IDMs) that integrate the fabrication of silicon wafers into their business; fabless companies, which outsource the manufacturing of silicon wafers; foundries that cater to the processing and manufacturing of silicon wafers; and outsourced sub-assembly and test providers, which offer test and assembly services for the final packaged devices to fabless companies and IDMs. It also provides Magnum test platform that test s memory devices, such as flash memory and dynamic random access memory, as well as offers ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets. The Systems Test Group segment offers military/aerospace test instrumentation and systems; storage test systems for HDD manufacturers; and circuit-board test and inspection systems for electronics manufacturers of cell phones, servers, computers, Internet switches, automobiles, and military avionics systems. The Wireless Test segment designs, develops, and supports wireless test solutions for developing and manufacturing wireless devices, such as smart phones, tablets, notebooks/laptops, and personal computer peripherals. This segment offers cellular communication solution for verification and calibration of mobile devices; and products for connectivity testing. The company was founded in 1960 and is headquartered in North Reading, Massac h usetts.

Advisors’ Opinion:

  • [By Patricio Kehoe]

    The concept of diversity, when talking about a company’s activities, is a sword with two edges. When performance hits the fan, diversity can turn into an advantage as only one segment can be affected. However, diversification can curtail winnings during a moment of bonanza. In other words, a company with five segments will see a relative smaller impact in overall performance than a company with activities in a single segment, when that segment experiences an abnormal growth. Hence, with a recovering construction market in the US and declining prices for mined commodities, a comparison between Caterpillar (CAT) and Terex (TER) is all the more relevant.

  • [By Rich Bieglmeier]

    Teradyne, Inc. (NYSE:TER) is on the move today, up more than 3% on Goldman Sachs upgrade and the general sentiment of a bounce back day. Analyst, James Covello added the semiconductor equipment company to the firm’s “Conviction Buy” list with a fresh, shiny, new price-target of $23 – potential upside of 22.86% to target.

Top Managed Healthcare Companies To Invest In Right Now: Southern Pacific Resource Corp (STPJF.PK)

Southern Pacific Resource Corp. (Southern Pacific) is engaged in the acquisition and development of heavy oil and bitumen producing properties, with a focus on thermal extraction in-situ oil sands projects in the Western Canadian sedimentary basin. Southern Pacific has two principal assets STP-McKay and STP-Senlac. The Company also holds additional oil sands leases in the McMurray and Peace River sub-basins in northeastern Alberta. The Company has 100% working interest in approximately 37,760 acres, of oil sands leases in McKay Block. Southern Pacific has its 100% working interest SAGD thermal heavy oil asset near Unity, Saskatchewan, STP-Senlac. In September 2013, the Company announced the closing of a disposition of non-core assets related to its Leismer property. Advisors’ Opinion:

  • [By Stephan Dube]

    Cold Lake’s most notable producers:

    Husky Energy (HUSK.PK), see article here.Pengrowth Energy Corporation (PGH), see article here.Southern Pacific Resource (STPJF.PK), see article here.Canadian Natural Resources (CNQ), see article here.Devon Energy (DVN), see article here.Imperial Oil (IMO), see article here.Baytex, see article here.Bonavista Energy (BNPUF.PK), see article here.

    Athabasca’s most notable producers:

Top Managed Healthcare Companies To Invest In Right Now: Baxter International Inc. (BAX)

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.

Advisors’ Opinion:

  • [By Holly LaFon]

    Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. As stated in the current prospectus, the Fund’s Investor Class Share’s annual operating expense ratio (gross) is 1.28%. The Fund’s adviser has contractually agreed to waive a portion of its fee and/or reimburse Fund expenses to limit total annual operating expenses at 1.25%, which is in effect until October 31, 2015. Other share classes may vary. The Fund charges a 2.0% redemption fee on shares redeemed within six months of purchase. For the most recent month-end performance, please call (877)328-9437 or visit the Advisor’s website at www.auxierasset.com. The recent growth rate in the stock market has helped to produce short-term returns that are not typical and may not continue in the future.Spring 2014 Market CommentaryAuxier Focus Fund’s Investor Class returned a modest 0.25% for the quarter ended March 31, while Standard and Poor’s 500 Stock Index (S&P) rose 1.81%. The Fund ended the quarter with 70% in U.S. stocks, 16% foreign stocks, 1.7 % bonds and 12.3% cash. Since inception in 1999, the Fund’s equity exposure has averaged 72%. Our stockholdings in the healthcare industry generally gained for the quarter. But many of our multinational and foreign stocks were hurt by the threat of currency repercussions from geopolitical events in Russia and Ukraine. The foreign portion of the Fund is easily the most undervalued. Longer term, we see a very favorable risk/reward potential with our UK and European holdings. Some emerging market companies we follow are the cheapest in over twenty years. In allocating capital, we much prefer the gloom of down to flat markets and the corrective process that tempers exuberance. We re member that one of th

  • [By Monica Gerson]

    Baxter International (NYSE: BAX) is expected to report its Q1 earnings at $1.09 per share on revenue of $3.88 billion.

    The Sherwin-Williams Company (NYSE: SHW) is projected to report its Q1 earnings at $1.11 per share on revenue of $2.36 billion.